Secretaria de Salud Publica Municipal de Cali
Cali, Valle del Cauca Department, 76001000, Colombia
NCT Number: NCT01945905
* Tuberculosis ( TB ) remains a major global public health problems and actions to ensure the diagnosis and complete treatment of all cases is the priority for the control of this disease. Despite the availability of effective anti-tuberculosis medications, there are still high levels of nonadherence to treatment. The nonadherence increases the morbidity and mortality of patients, decreases the cure rate, increases the community transmission and the increase of chronically ill patients enables the emergence of multi - drug resistant and increases treatment costs. * Despite the knowledge about different forms of cost-effective delivery of DOT (directly observed treatment), recognition of the need to establish the DOT strategy related to the context from local studies, in Colombia and in Cali we hadn't had made studies similar than this one that establish the cost and results of the current DOT delivery strategy and to identify other ways to improve adherence and cure rate for the TB patients at reasonable cost for both: health services and families * Therefore, this research aims to compare the cost -effectiveness of current DOT delivery method with an alternative extra- institutional delivery of anti -TB treatment in urban areas of Cali. A cost-effectiveness study was conducted from the institutional and familiar perspective with prospective information collection.
Looking for future studies?
Notify Me15 year and older
All sexes
Interventional
Not applicable
Cali, Valle del Cauca Department, 76001000, Colombia
We compared two strategies for anti- TB treatment delivery: one institutional in which patients went to health institutions to receive treatment and other extra- institutional in which the medication was delivered in the place of choice for treating patients.
Measuring the effectiveness ( compliance and cure ) was made from a controlled clinical trial , randomized , partially blinded . The measurement of family and institutional costs , direct and indirect , will be based on the activities.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Under this alternative, the patients will receive treatment with direct observation from health team. Treatment will be provided for free
In this form the medication will be given by a health worker in the place chosen by patients. This option will be delivered to patients with newly diagnosed pulmonary TB without hospitalization criteria
Time frame: Participants will be followed for the duration of the treatment, an expected average of six months
Total of patients who completed de treatment
Time frame: Participants will be followed for the duration of the treatment, an expected average of six months
Total number of patients who completed the treatment and had the last or the two last smear negative and had negative cultures at the end of the treatment
Fundación FES
Other
Cost-effectiveness of Two Forms of Delivery of Directly Observed Treatment in a Demonstration Area of the DOTS Strategy in Colombia
Acronym: DOTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04968886
Actinomycetales Infections, Bacterial Infections
Le Kremlin-Bicêtre, France
View Trial DetailsNCT05007821
Actinomycetales Infections, Bacterial Infections
Gaborone, South-East District, Botswana
View Trial DetailsNCT04752592
Actinomycetales Infections, Bacterial Infections
Awasa, Ethiopia
View Trial DetailsNCT03512249
Actinomycetales Infections, Bacterial Infections
Bellville, Cape Town, South Africa
View Trial Details